Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
Newcastle Disease Virus as a Vaccine Vector for SARS-CoV-2
oleh: Edris Shirvani, Siba K. Samal
Format: | Article |
---|---|
Diterbitkan: | MDPI AG 2020-07-01 |
Deskripsi
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in more than 16 million infections and more than 600,000 deaths worldwide. There is an urgent need to develop a safe and effective vaccine against SARS-CoV-2. Currently, several strategies are being pursued to develop a safe and effective SARS-CoV-2 vaccine. However, each vaccine strategy has distinct advantages and disadvantages. Therefore, it is important to evaluate multiple vaccine platforms to select the most efficient vaccine platform for SARS-CoV-2. In this regard, Newcastle disease virus (NDV), an avian virus, has several well-suited properties for development of a vector vaccine against SARS-CoV-2. Here, we elaborate on the idea of considering NDV as a vaccine vector for SARS-CoV-2.